What You Should Know:
– Atropos Health, a pioneer in real-world evidence (RWE) generation, announced a collaboration with Merck to leverage its innovative platform for rapid insights and analytics from real-world data (RWD).
– The strategic partnership will enable Merck’s data science and RWE teams to conduct advanced analyses and generate publication-grade studies in less than 48 hours.
– The collaboration follows Atropos Health’s recent launch of ChatRWD™, a groundbreaking generative AI application for rapid RWE generation. In May 2024, the company also secured $33M in funding to advance its AI-driven approach to health data analysis.
Accelerating RWE for Life Savings Treatments
Merck will utilize a suite of Atropos Health’s services, including:
- GENEVA OS™: A generative evidence acceleration operating system that facilitates rapid cohort creation and advanced analytics.
- Green Button™: A tool that simplifies the process of asking clinical questions and generating RWE.
- Atropos Evidence™ Network: Access to the industry’s largest federated healthcare data network, with over 300 million patient records.
- Alexandria™: A repository of existing studies that can be rerun on local data to generate novel insights.
- Forge™: A low-code research platform for rapid cohort creation and advanced patient studies.
- ChatRWD™: A generative AI co-pilot that delivers full observational studies on healthcare data in minutes.
Through these tools, Merck’s teams will collaborate closely with Atropos Health’s data scientists, technologists, and researchers to accelerate evidence generation and drive faster insights.
Real-World Data at Scale
Atropos Health’s platform offers several key advantages:
- Access to vast RWD: Provides access to a comprehensive and diverse dataset through the Atropos Evidence Network.
- Data quality assessment: Utilizes the Real World Fitness Score to evaluate the appropriateness and quality of data for each research question.
- Rapid evidence generation: Enables the creation of publication-grade studies in less than 48 hours.
- AI-powered insights: Leverages AI to accelerate analysis and generate real-world evidence in minutes.
“Decisions based on RWE are becoming a reality and the speed of medicine requires quality data to be available for translation into accurate RWE rapidly.” said Dr. Brigham Hyde, CEO and co-founder at Atropos Health. “This collaboration accelerates the rate at which insights for decision making are presented and acted upon, improving the pace of innovation that ultimately improves patient care.”
